Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation

Vokurka, Samuel; Skardova, Jana; Karas, Michal; Kostková, Jana; Steinerová, Kateřina; Koza, Vladimír; Bystřická, Eva

doi:10.1016/j.jpainsymman.2010.02.003

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation

Abstract: Laryngospasm is an involuntary contraction of the intrinsic muscles that control the vocal This study was supported in part by grants from the Chinese National Foundation of Natural Sciences (30871141, 30770958).

Cited by 5 publications

References 6 publications

Use of a buprenorphine-based pain management protocol is associated with reduced opioid requirements and pain on swallowing in oral mucositis: a retrospective cohort study

Use of a buprenorphine-based pain management protocol is associated with reduced opioid requirements and pain on swallowing in oral mucositis: a retrospective cohort study

Iatrogenic disease

Clinical Update: Prevention and Management of Oral Mucositis in Patients with Cancer

Contact Info

Product

Resources

About